Most cited papers from Abcam (United States)

Abcam (United States)

What are the most cited papers from Abcam (United States)?

The most cited paper from Abcam (United States) is "Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe" (Michel Warny, Jacques Pepin, Aiqi Fang et al., 2005), with 1,445 citations. Next come "Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon" (812) and "Yellow fever: an update" (541).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 60 papers. Every paper with more than 64 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe Michel Warny, Jacques Pepin, Aiqi Fang et al. · The Lancet	Sep 2005	1,445
2	Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon Agnès Le Bon, Nathalie Etchart, Cornelia Rossmann et al. · Nature Immunology	21 Sep 2003	812
3	Yellow fever: an update Thomas P. C. Monath · The Lancet Infectious Diseases	Aug 2001	541
4	Yellow fever vaccine Thomas P. C. Monath · Expert Review of Vaccines	Aug 2005	468
5	Universal Vaccine Based on Ectodomain of Matrix Protein 2 of Influenza A: Fc Receptors and Alveolar Macrophages Mediate Protection Karim El Bakkouri, Francis J. Descamps, Marina De Filette et al. · The Journal of Immunology Open access	17 Dec 2010	340
6	Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases Pedro FC Vasconcelos et al. · The Lancet Open access	Jul 2001	286
7	Safety and Efficacy of Chimeric Yellow Fever-Dengue Virus Tetravalent Vaccine Formulations in Nonhuman Primates Farshad Guirakhoo, Konstantin V. Pugachev, Z. Zhang et al. · Journal of Virology Open access	12 Apr 2004	256
8	Application of phage display to high throughput antibody generation and characterization Darren J. Schofield et al. · Genome biology Open access	29 Nov 2007	237
9	A live, attenuated recombinant West Nile virus vaccine Thomas P. C. Monath, Jian Liu, Niranjan Kanesa-thasan et al. · Proceedings of the National Academy of Sciences Open access	14 Apr 2006	230
10	The Parkinson's disease VPS35[D620N] mutation enhances LRRK2-mediated Rab protein phosphorylation in mouse and human Rafeeq Mir, Francesca Tonelli, Paweł Lis et al. · Biochemical Journal Open access	9 May 2018	224
11	Construction, Safety, and Immunogenicity in Nonhuman Primates of a Chimeric Yellow Fever-Dengue Virus Tetravalent Vaccine Farshad Guirakhoo, Juan Arroyo, Konstantin V. Pugachev et al. · Journal of Virology Open access	15 Aug 2001	224
12	Clinical proof of principle for ChimeriVax™: recombinant live, attenuated vaccines against flavivirus infections Thomas P. C. Monath, Karen P. McCarthy, Philip Bedford et al. · Vaccine	2002	221
13	Chimeric Live, Attenuated Vaccine against Japanese Encephalitis (ChimeriVax‐JE): Phase 2 Clinical Trials for Safety and Immunogenicity, Effect of Vaccine Dose and Schedule, and Memory Response to Challenge with Inactivated Japanese Encephalitis Antigen Thomas P. C. Monath, Farshad Guirakhoo, Richard Nichols et al. · The Journal of Infectious Diseases	13 Oct 2003	219
14	Toxinotype VClostridium difficilein Humans and Food Animals Michael A. Jhung, Angela D. Thompson, George Killgore et al. · Emerging infectious diseases Open access	Jul 2008	216
15	Gut microbiome and serum metabolome analyses identify molecular biomarkers and altered glutamate metabolism in fibromyalgia Marc Clos‐Garcia et al. · EBioMedicine Open access	18 Jul 2019	208
16	Live Attenuated Chimeric Yellow Fever Dengue Type 2 (ChimeriVax™-DEN2) Vaccine: Phase I Clinical Trial for Safety and Immunogenicity: Effect of Yellow Fever Pre-immunity in Induction of Cross Neutralizing Antibody Responses to All Farshad Guirakhoo, Scott J. Kitchener, Dennis Morrison et al. · Human Vaccines Open access	3 Mar 2006	193
17	Comparative safety and immunogenicity of two yellow fever 17D vaccines (ARILVAX and YF-VAX) in a phase III multicenter, double-blind clinical trial. Thomas P. C. Monath, Richard Nichols, W. Tad Archambault et al. · American Journal of Tropical Medicine and Hygiene	May 2002	179
18	The Ventral Hippocampus Is the Embryonic Origin for Adult Neural Stem Cells in the Dentate Gyrus Guangnan Li, Fang Li, Gloria Fernández et al. · Neuron Open access	May 2013	173
19	Development of phospho-specific Rab protein antibodies to monitor in vivo activity of the LRRK2 Parkinson's disease kinase Paweł Lis, Sophie Burel, Martin Steger et al. · Biochemical Journal Open access	11 Nov 2017	170
20	Prevention of Yellow Fever in Persons Traveling to the Tropics Thomas P. C. Monath, Martín S. Cetron · Clinical Infectious Diseases	15 May 2002	160
21	A guerra das mães: dor e política em situações de violência institucional Adriana R. B. Vianna, Juliana Farias · Cadernos Pagu Open access	23 Nov 2011	159
22	The CARMENES search for exoplanets around M dwarfs Trifon Trifonov et al. · Astronomy and Astrophysics Open access169 authors	27 Sep 2017	157
23	Safety and Immunogenicity of Increasing Doses of a Clostridium difficile Toxoid Vaccine Administered to Healthy Adults Karen L. Kotloff, Steven S. Wasserman, Genevieve A. Losonsky et al. · Infection and Immunity Open access	Feb 2001	157
24	Clonal vaccinia virus grown in cell culture as a new smallpox vaccine Richard Weltzin, Jian Liu, Konstantin V. Pugachev et al. · Nature Medicine	17 Aug 2003	156
25	Single Mutation in the Flavivirus Envelope Protein Hinge Region Increases Neurovirulence for Mice and Monkeys but Decreases Viscerotropism for Monkeys: Relevance to Development and Safety Testing of Live, Attenuated Vaccines Thomas P. C. Monath, Juan Arroyo, Inessa S. Levenbook et al. · Journal of Virology Open access	15 Feb 2002	151
26	Viremia and Immunogenicity in Nonhuman Primates of a Tetravalent Yellow Fever–Dengue Chimeric Vaccine: Genetic Reconstructions, Dose Adjustment, and Antibody Responses against Wild-type Dengue Virus Isolates Farshad Guirakhoo, Konstantin V. Pugachev, Juan Arroyo et al. · Virology Open access	Jun 2002	149
27	Epidemiology and ecology of yellow fever virus Alan D.T. Barrett, Thomas P. C. Monath · Advances in virus research Book chapter	2003	149
28	ACAM2000 clonal Vero cell culture vaccinia virus (New York City Board of Health strain) – a second-generation smallpox vaccine for biological defense Thomas P. C. Monath, Joseph R. Caldwell, Wolfgang Mundt et al. · International Journal of Infectious Diseases Open access	Oct 2004	148
29	Efficacy of Killed Virus Vaccine, Live Attenuated Chimeric Virus Vaccine, and Passive Immunization for Prevention ofWest Nile virusEncephalitis in Hamster Model Robert B. Tesh, Juan Arroyo, Amélia P. A. Travassos da Rosa et al. · Emerging infectious diseases Open access	Dec 2002	147
30	The Function of the Minoan Palaces Norberto Luiz Guarinello · Revista de História Open access	30 Dec 1989	142
31	Exosomal MicroRNA-15a Transfer from the Pancreas Augments Diabetic Complications by Inducing Oxidative Stress Tengku Ain Kamalden, Anne M. Macgregor-Das, Sangeetha Marimuthu Kannan et al. · Antioxidants and Redox Signaling Open access	8 Feb 2017	141
32	Cadherin-17 and SATB2 Are Sensitive and Specific Immunomarkers for Medullary Carcinoma of the Large Intestine Fan Lin, Jianhui Shi, Shaobo Zhu et al. · Archives of Pathology & Laboratory Medicine Open access	17 Jan 2014	137
33	Active and passive immunization against Clostridium difficile diarrhea and colitis Paul J. Giannasca, Michel Warny · Vaccine	13 Dec 2003	121
34	Cutaneous Delivery of a Live, Attenuated Chimeric Flavivirus Vaccines against Japanese Encephalitis (ChimeriVaxTM-JE) in Non-Human Primates Cheryl H. Dean, Jason B. Alarcon, Andrea M. Waterston et al. · Human Vaccines Open access	May 2005	113
35	High Fidelity of Yellow Fever Virus RNA Polymerase Konstantin V. Pugachev, Farshad Guirakhoo, S. Ocran et al. · Journal of Virology Open access	23 Dec 2003	109
36	Phenotypic and Molecular Analyses of Yellow Fever 17DD Vaccine Viruses Associated with Serious Adverse Events in Brazil Ricardo Galler, Konstantin V. Pugachev, Cecília L. S. Santos et al. · Virology Open access	Nov 2001	107
37	Chimeric Flaviviruses: Novel Vaccines against Dengue Fever, Tick-borne Encephalitis, and Japanese Encephalitis Ching‐Juh Lai, Thomas P. C. Monath · Advances in virus research Book chapter	2003	105
38	Yellow Fever 17D Vaccine Safety and Immunogenicity in the Elderly Thomas P. C. Monath, Martín S. Cetron, Karen P. McCarthy et al. · Human Vaccines Open access	4 Sep 2005	104
39	Japanese Encephalitis Vaccines: Current Vaccines and Future Prospects Thomas P. C. Monath · Current topics in microbiology and immunology Book chapter	2002	102
40	Prospects for Development of a Vaccine against the West Nile Virus Thomas P. C. Monath · Annals of the New York Academy of Sciences	Dec 2001	97
41	Distribution of the Ixodes ricinus-like ticks of eastern North America. Stephen M. Rich, D A Caporale, Sam R. Telford et al. · Proceedings of the National Academy of Sciences Open access	3 Jul 1995	95
42	Comparison of the safety and immunogenicity of ACAM1000, ACAM2000 and Dryvax® in healthy vaccinia-naive adults Sharon E. Frey, Frances K. Newman, Jeffrey S. Kennedy et al. · Vaccine	10 Dec 2008	94
43	Helicobacter pyloriReinfection Is Common in Peruvian Adults after Antibiotic Eradication Therapy Giselle M. Soto, Christian T. Bautista, Daniel E. Roth et al. · The Journal of Infectious Diseases	31 Oct 2003	90
44	[ 18 F]CFA as a clinically translatable probe for PET imaging of deoxycytidine kinase activity Woo-Suk Kim et al. · Proceedings of the National Academy of Sciences Open access	28 Mar 2016	89
45	New developments in flavivirus vaccines with special attention to yellow fever Konstantin V. Pugachev, Farshad Guirakhoo, Thomas P. C. Monath · Current Opinion in Infectious Diseases	13 Sep 2005	88
46	RUC-4 Jihong Li, Spandana Vootukuri, Yi Shang et al. · Arteriosclerosis Thrombosis and Vascular Biology Open access	22 Aug 2014	86
47	Algorithms for Noisy Problems in Gas Transmission Pipeline Optimization R.G. Carter, Joerg M. Gablonsky, A. Patrick et al. · Optimization and Engineering	Jun 2001	86
48	A novel, cell culture-derived smallpox vaccine in vaccinia-naïve adults Andrew W. Artenstein, Casey Johnson, Thomas C Marbury et al. · Vaccine	29 Jan 2005	84
49	Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax™-JE experimental vaccine David W. C. Beasley, Li Li, Miguel T. Suderman et al. · Vaccine	13 Apr 2004	81
50	Experimental Infection of Rhesus Macaques with West Nile Virus: Level and Duration of Viremia and Kinetics of the Antibody Response after Infection Marion S. Ratterree, Robin A. Gutierrez, Amélia P. A. Travassos da Rosa et al. · The Journal of Infectious Diseases Open access	11 Feb 2004	79

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.